nodes	percent_of_prediction	percent_of_DWPC	metapath
Raloxifene—ESR2—brain cancer	0.74	1	CbGaD
Raloxifene—CYP3A4—Temozolomide—brain cancer	0.0319	0.39	CbGbCtD
Raloxifene—CYP3A4—Lomustine—brain cancer	0.0271	0.332	CbGbCtD
Raloxifene—CYP2C8—Etoposide—brain cancer	0.0162	0.198	CbGbCtD
Raloxifene—CYP3A4—Etoposide—brain cancer	0.00655	0.0802	CbGbCtD
Raloxifene—HTR6—ganglion—brain cancer	0.0035	0.0928	CbGeAlD
Raloxifene—Gastrointestinal symptom NOS—Hydroxyurea—brain cancer	0.00194	0.027	CcSEcCtD
Raloxifene—ESR2—hindbrain—brain cancer	0.00186	0.0494	CbGeAlD
Raloxifene—Neoplasm malignant—Procarbazine—brain cancer	0.00172	0.024	CcSEcCtD
Raloxifene—EBP—endocrine gland—brain cancer	0.00172	0.0456	CbGeAlD
Raloxifene—Deep vein thrombosis—Temozolomide—brain cancer	0.00146	0.0204	CcSEcCtD
Raloxifene—Embolism—Temozolomide—brain cancer	0.00139	0.0193	CcSEcCtD
Raloxifene—HTR6—telencephalon—brain cancer	0.00135	0.0358	CbGeAlD
Raloxifene—ESR1—blood vessel—brain cancer	0.00134	0.0355	CbGeAlD
Raloxifene—Tenderness—Hydroxyurea—brain cancer	0.0013	0.0182	CcSEcCtD
Raloxifene—ESR1—hindbrain—brain cancer	0.00128	0.0339	CbGeAlD
Raloxifene—Vaginal haemorrhage—Temozolomide—brain cancer	0.0012	0.0168	CcSEcCtD
Raloxifene—ESR2—brainstem—brain cancer	0.00107	0.0283	CbGeAlD
Raloxifene—Breast pain—Temozolomide—brain cancer	0.00102	0.0142	CcSEcCtD
Raloxifene—ESR2—telencephalon—brain cancer	0.000947	0.0251	CbGeAlD
Raloxifene—Infection—Carboplatin—brain cancer	0.000939	0.0131	CcSEcCtD
Raloxifene—Pulmonary embolism—Carmustine—brain cancer	0.00092	0.0128	CcSEcCtD
Raloxifene—Vaginal inflammation—Temozolomide—brain cancer	0.000889	0.0124	CcSEcCtD
Raloxifene—Pulmonary embolism—Temozolomide—brain cancer	0.000889	0.0124	CcSEcCtD
Raloxifene—HTR6—head—brain cancer	0.00084	0.0223	CbGeAlD
Raloxifene—Vaginal infection—Temozolomide—brain cancer	0.00084	0.0117	CcSEcCtD
Raloxifene—Pneumonia—Procarbazine—brain cancer	0.000828	0.0115	CcSEcCtD
Raloxifene—Infection—Lomustine—brain cancer	0.000821	0.0115	CcSEcCtD
Raloxifene—Thrombocytopenia—Lomustine—brain cancer	0.000809	0.0113	CcSEcCtD
Raloxifene—Pain—Carboplatin—brain cancer	0.000808	0.0113	CcSEcCtD
Raloxifene—ESR2—gonad—brain cancer	0.00079	0.021	CbGeAlD
Raloxifene—Sweating—Procarbazine—brain cancer	0.000789	0.011	CcSEcCtD
Raloxifene—ESR2—pituitary gland—brain cancer	0.000771	0.0205	CbGeAlD
Raloxifene—Diabetes mellitus—Carmustine—brain cancer	0.000768	0.0107	CcSEcCtD
Raloxifene—HTR6—central nervous system—brain cancer	0.000767	0.0204	CbGeAlD
Raloxifene—AOX1—gonad—brain cancer	0.000761	0.0202	CbGeAlD
Raloxifene—Body temperature increased—Carboplatin—brain cancer	0.000747	0.0104	CcSEcCtD
Raloxifene—Breast disorder—Hydroxyurea—brain cancer	0.000747	0.0104	CcSEcCtD
Raloxifene—AOX1—pituitary gland—brain cancer	0.000742	0.0197	CbGeAlD
Raloxifene—SIGMAR1—telencephalon—brain cancer	0.000734	0.0195	CbGeAlD
Raloxifene—HTR2B—telencephalon—brain cancer	0.000732	0.0194	CbGeAlD
Raloxifene—ESR1—brainstem—brain cancer	0.000731	0.0194	CbGeAlD
Raloxifene—Gastroenteritis—Temozolomide—brain cancer	0.000728	0.0102	CcSEcCtD
Raloxifene—Hot flush—Temozolomide—brain cancer	0.00069	0.00962	CcSEcCtD
Raloxifene—Flushing—Procarbazine—brain cancer	0.000686	0.00956	CcSEcCtD
Raloxifene—Menopausal symptoms—Temozolomide—brain cancer	0.000684	0.00954	CcSEcCtD
Raloxifene—Body temperature increased—Lomustine—brain cancer	0.000653	0.00911	CcSEcCtD
Raloxifene—Weight increased—Hydroxyurea—brain cancer	0.00065	0.00906	CcSEcCtD
Raloxifene—ESR1—telencephalon—brain cancer	0.000649	0.0172	CbGeAlD
Raloxifene—CYP19A1—gonad—brain cancer	0.000623	0.0165	CbGeAlD
Raloxifene—HTR6—brain—brain cancer	0.000609	0.0162	CbGeAlD
Raloxifene—SIGMAR1—pituitary gland—brain cancer	0.000597	0.0159	CbGeAlD
Raloxifene—ESR2—endocrine gland—brain cancer	0.000597	0.0159	CbGeAlD
Raloxifene—ESR2—head—brain cancer	0.00059	0.0157	CbGeAlD
Raloxifene—Breast disorder—Temozolomide—brain cancer	0.000583	0.00814	CcSEcCtD
Raloxifene—Aspartate aminotransferase increased—Temozolomide—brain cancer	0.000581	0.00811	CcSEcCtD
Raloxifene—Syncope—Procarbazine—brain cancer	0.000577	0.00804	CcSEcCtD
Raloxifene—SIGMAR1—medulla oblongata—brain cancer	0.000576	0.0153	CbGeAlD
Raloxifene—AOX1—endocrine gland—brain cancer	0.000575	0.0153	CbGeAlD
Raloxifene—Loss of consciousness—Procarbazine—brain cancer	0.000565	0.00788	CcSEcCtD
Raloxifene—Cough—Procarbazine—brain cancer	0.000561	0.00783	CcSEcCtD
Raloxifene—Myalgia—Procarbazine—brain cancer	0.000547	0.00763	CcSEcCtD
Raloxifene—Arthralgia—Procarbazine—brain cancer	0.000547	0.00763	CcSEcCtD
Raloxifene—ESR1—gonad—brain cancer	0.000541	0.0144	CbGeAlD
Raloxifene—ESR2—central nervous system—brain cancer	0.000538	0.0143	CbGeAlD
Raloxifene—Bronchitis—Temozolomide—brain cancer	0.000537	0.00748	CcSEcCtD
Raloxifene—ESR1—pituitary gland—brain cancer	0.000528	0.014	CbGeAlD
Raloxifene—SIGMAR1—midbrain—brain cancer	0.000527	0.014	CbGeAlD
Raloxifene—ESR2—cerebellum—brain cancer	0.000526	0.014	CbGeAlD
Raloxifene—Vomiting—Lomustine—brain cancer	0.000526	0.00733	CcSEcCtD
Raloxifene—Infection—Procarbazine—brain cancer	0.000521	0.00727	CcSEcCtD
Raloxifene—Angiopathy—Hydroxyurea—brain cancer	0.000519	0.00723	CcSEcCtD
Raloxifene—Pneumonia—Carmustine—brain cancer	0.000518	0.00722	CcSEcCtD
Raloxifene—Shock—Procarbazine—brain cancer	0.000516	0.0072	CcSEcCtD
Raloxifene—SIGMAR1—spinal cord—brain cancer	0.000514	0.0137	CbGeAlD
Raloxifene—Thrombocytopenia—Procarbazine—brain cancer	0.000514	0.00717	CcSEcCtD
Raloxifene—Depression—Carmustine—brain cancer	0.000513	0.00716	CcSEcCtD
Raloxifene—Weight increased—Temozolomide—brain cancer	0.000508	0.00708	CcSEcCtD
Raloxifene—Hyperhidrosis—Procarbazine—brain cancer	0.000507	0.00708	CcSEcCtD
Raloxifene—AOX1—cerebellum—brain cancer	0.000506	0.0134	CbGeAlD
Raloxifene—Urinary tract infection—Carmustine—brain cancer	0.0005	0.00698	CcSEcCtD
Raloxifene—Pneumonia—Temozolomide—brain cancer	0.0005	0.00698	CcSEcCtD
Raloxifene—Depression—Temozolomide—brain cancer	0.000496	0.00692	CcSEcCtD
Raloxifene—Nausea—Lomustine—brain cancer	0.000491	0.00685	CcSEcCtD
Raloxifene—Urinary tract infection—Temozolomide—brain cancer	0.000484	0.00674	CcSEcCtD
Raloxifene—Musculoskeletal discomfort—Procarbazine—brain cancer	0.000478	0.00667	CcSEcCtD
Raloxifene—Insomnia—Procarbazine—brain cancer	0.000475	0.00662	CcSEcCtD
Raloxifene—CYP19A1—endocrine gland—brain cancer	0.000471	0.0125	CbGeAlD
Raloxifene—Sinusitis—Temozolomide—brain cancer	0.000467	0.00651	CcSEcCtD
Raloxifene—CYP19A1—head—brain cancer	0.000465	0.0123	CbGeAlD
Raloxifene—Hypoaesthesia—Carmustine—brain cancer	0.00046	0.00641	CcSEcCtD
Raloxifene—HTR2B—head—brain cancer	0.000456	0.0121	CbGeAlD
Raloxifene—Oedema peripheral—Carmustine—brain cancer	0.000455	0.00635	CcSEcCtD
Raloxifene—Connective tissue disorder—Carmustine—brain cancer	0.000454	0.00633	CcSEcCtD
Raloxifene—Pain—Procarbazine—brain cancer	0.000449	0.00626	CcSEcCtD
Raloxifene—Hypoaesthesia—Temozolomide—brain cancer	0.000444	0.0062	CcSEcCtD
Raloxifene—Pharyngitis—Temozolomide—brain cancer	0.000443	0.00618	CcSEcCtD
Raloxifene—Urinary tract disorder—Temozolomide—brain cancer	0.000441	0.00615	CcSEcCtD
Raloxifene—Oedema peripheral—Temozolomide—brain cancer	0.00044	0.00614	CcSEcCtD
Raloxifene—Connective tissue disorder—Temozolomide—brain cancer	0.000439	0.00612	CcSEcCtD
Raloxifene—Urethral disorder—Temozolomide—brain cancer	0.000438	0.00611	CcSEcCtD
Raloxifene—CYP2C8—pituitary gland—brain cancer	0.000435	0.0116	CbGeAlD
Raloxifene—Gastrointestinal pain—Procarbazine—brain cancer	0.000429	0.00598	CcSEcCtD
Raloxifene—Flushing—Carmustine—brain cancer	0.000429	0.00598	CcSEcCtD
Raloxifene—ESR2—brain—brain cancer	0.000427	0.0113	CbGeAlD
Raloxifene—CYP19A1—central nervous system—brain cancer	0.000424	0.0113	CbGeAlD
Raloxifene—Unspecified disorder of skin and subcutaneous tissue—Hydroxyurea—brain cancer	0.000421	0.00587	CcSEcCtD
Raloxifene—HTR2B—central nervous system—brain cancer	0.000416	0.011	CbGeAlD
Raloxifene—Abdominal pain—Procarbazine—brain cancer	0.000415	0.00579	CcSEcCtD
Raloxifene—Body temperature increased—Procarbazine—brain cancer	0.000415	0.00579	CcSEcCtD
Raloxifene—Flushing—Temozolomide—brain cancer	0.000414	0.00578	CcSEcCtD
Raloxifene—Cardiac disorder—Temozolomide—brain cancer	0.000414	0.00578	CcSEcCtD
Raloxifene—AOX1—brain—brain cancer	0.000411	0.0109	CbGeAlD
Raloxifene—ESR1—endocrine gland—brain cancer	0.000409	0.0109	CbGeAlD
Raloxifene—SIGMAR1—cerebellum—brain cancer	0.000408	0.0108	CbGeAlD
Raloxifene—Angiopathy—Temozolomide—brain cancer	0.000405	0.00565	CcSEcCtD
Raloxifene—ESR1—head—brain cancer	0.000404	0.0107	CbGeAlD
Raloxifene—Infection—Hydroxyurea—brain cancer	0.000403	0.00563	CcSEcCtD
Raloxifene—Pneumonia—Etoposide—brain cancer	0.0004	0.00558	CcSEcCtD
Raloxifene—CYP2B6—gonad—brain cancer	0.0004	0.0106	CbGeAlD
Raloxifene—Nervous system disorder—Hydroxyurea—brain cancer	0.000398	0.00555	CcSEcCtD
Raloxifene—Thrombocytopenia—Hydroxyurea—brain cancer	0.000398	0.00555	CcSEcCtD
Raloxifene—Skin disorder—Hydroxyurea—brain cancer	0.000394	0.0055	CcSEcCtD
Raloxifene—ESR1—central nervous system—brain cancer	0.000369	0.00979	CbGeAlD
Raloxifene—ESR1—cerebellum—brain cancer	0.00036	0.00957	CbGeAlD
Raloxifene—Diarrhoea—Procarbazine—brain cancer	0.000359	0.00501	CcSEcCtD
Raloxifene—Dyspepsia—Hydroxyurea—brain cancer	0.000357	0.00499	CcSEcCtD
Raloxifene—Hypoaesthesia—Etoposide—brain cancer	0.000356	0.00496	CcSEcCtD
Raloxifene—Urinary tract disorder—Etoposide—brain cancer	0.000353	0.00492	CcSEcCtD
Raloxifene—Gastrointestinal disorder—Hydroxyurea—brain cancer	0.000351	0.00489	CcSEcCtD
Raloxifene—Urethral disorder—Etoposide—brain cancer	0.00035	0.00489	CcSEcCtD
Raloxifene—Vertigo—Temozolomide—brain cancer	0.000349	0.00487	CcSEcCtD
Raloxifene—Pain—Hydroxyurea—brain cancer	0.000347	0.00484	CcSEcCtD
Raloxifene—Dizziness—Procarbazine—brain cancer	0.000347	0.00484	CcSEcCtD
Raloxifene—Myalgia—Carmustine—brain cancer	0.000342	0.00478	CcSEcCtD
Raloxifene—Chest pain—Carmustine—brain cancer	0.000342	0.00478	CcSEcCtD
Raloxifene—Cough—Temozolomide—brain cancer	0.000339	0.00473	CcSEcCtD
Raloxifene—CYP2C8—endocrine gland—brain cancer	0.000337	0.00895	CbGeAlD
Raloxifene—CYP19A1—brain—brain cancer	0.000337	0.00894	CbGeAlD
Raloxifene—Vomiting—Procarbazine—brain cancer	0.000334	0.00465	CcSEcCtD
Raloxifene—Flushing—Etoposide—brain cancer	0.000332	0.00463	CcSEcCtD
Raloxifene—Cardiac disorder—Etoposide—brain cancer	0.000332	0.00463	CcSEcCtD
Raloxifene—SIGMAR1—brain—brain cancer	0.000331	0.00879	CbGeAlD
Raloxifene—Arthralgia—Temozolomide—brain cancer	0.000331	0.00462	CcSEcCtD
Raloxifene—Myalgia—Temozolomide—brain cancer	0.000331	0.00462	CcSEcCtD
Raloxifene—Rash—Procarbazine—brain cancer	0.000331	0.00461	CcSEcCtD
Raloxifene—Dermatitis—Procarbazine—brain cancer	0.000331	0.00461	CcSEcCtD
Raloxifene—HTR2B—brain—brain cancer	0.00033	0.00877	CbGeAlD
Raloxifene—Headache—Procarbazine—brain cancer	0.000329	0.00458	CcSEcCtD
Raloxifene—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—brain cancer	0.000329	0.00458	CcSEcCtD
Raloxifene—Infection—Carmustine—brain cancer	0.000326	0.00455	CcSEcCtD
Raloxifene—Angiopathy—Etoposide—brain cancer	0.000324	0.00452	CcSEcCtD
Raloxifene—Thrombocytopenia—Carmustine—brain cancer	0.000321	0.00448	CcSEcCtD
Raloxifene—Body temperature increased—Hydroxyurea—brain cancer	0.000321	0.00448	CcSEcCtD
Raloxifene—Infection—Temozolomide—brain cancer	0.000315	0.0044	CcSEcCtD
Raloxifene—Nausea—Procarbazine—brain cancer	0.000312	0.00435	CcSEcCtD
Raloxifene—Nervous system disorder—Temozolomide—brain cancer	0.000311	0.00434	CcSEcCtD
Raloxifene—Thrombocytopenia—Temozolomide—brain cancer	0.000311	0.00433	CcSEcCtD
Raloxifene—Skin disorder—Temozolomide—brain cancer	0.000308	0.0043	CcSEcCtD
Raloxifene—Hyperhidrosis—Temozolomide—brain cancer	0.000307	0.00428	CcSEcCtD
Raloxifene—CYP2B6—endocrine gland—brain cancer	0.000302	0.00803	CbGeAlD
Raloxifene—Musculoskeletal discomfort—Carmustine—brain cancer	0.000299	0.00417	CcSEcCtD
Raloxifene—Muscle spasms—Etoposide—brain cancer	0.000299	0.00417	CcSEcCtD
Raloxifene—CYP2B6—head—brain cancer	0.000298	0.00793	CbGeAlD
Raloxifene—Insomnia—Carmustine—brain cancer	0.000297	0.00414	CcSEcCtD
Raloxifene—ESR1—brain—brain cancer	0.000293	0.00777	CbGeAlD
Raloxifene—Musculoskeletal discomfort—Temozolomide—brain cancer	0.000289	0.00403	CcSEcCtD
Raloxifene—Insomnia—Temozolomide—brain cancer	0.000287	0.004	CcSEcCtD
Raloxifene—Gastrointestinal disorder—Carmustine—brain cancer	0.000283	0.00395	CcSEcCtD
Raloxifene—Pain—Carmustine—brain cancer	0.000281	0.00392	CcSEcCtD
Raloxifene—Vertigo—Etoposide—brain cancer	0.000279	0.0039	CcSEcCtD
Raloxifene—Dyspepsia—Temozolomide—brain cancer	0.000279	0.0039	CcSEcCtD
Raloxifene—Diarrhoea—Hydroxyurea—brain cancer	0.000278	0.00388	CcSEcCtD
Raloxifene—Gastrointestinal disorder—Temozolomide—brain cancer	0.000274	0.00382	CcSEcCtD
Raloxifene—Loss of consciousness—Etoposide—brain cancer	0.000273	0.00381	CcSEcCtD
Raloxifene—CYP2B6—central nervous system—brain cancer	0.000272	0.00723	CbGeAlD
Raloxifene—Cough—Etoposide—brain cancer	0.000271	0.00379	CcSEcCtD
Raloxifene—Pain—Temozolomide—brain cancer	0.000271	0.00378	CcSEcCtD
Raloxifene—Dizziness—Hydroxyurea—brain cancer	0.000269	0.00375	CcSEcCtD
Raloxifene—Gastrointestinal pain—Carmustine—brain cancer	0.000268	0.00374	CcSEcCtD
Raloxifene—Chest pain—Etoposide—brain cancer	0.000265	0.00369	CcSEcCtD
Raloxifene—Unspecified disorder of skin and subcutaneous tissue—Etoposide—brain cancer	0.000263	0.00367	CcSEcCtD
Raloxifene—Body temperature increased—Carmustine—brain cancer	0.00026	0.00362	CcSEcCtD
Raloxifene—Abdominal pain—Carmustine—brain cancer	0.00026	0.00362	CcSEcCtD
Raloxifene—Gastrointestinal pain—Temozolomide—brain cancer	0.000259	0.00362	CcSEcCtD
Raloxifene—Vomiting—Hydroxyurea—brain cancer	0.000258	0.0036	CcSEcCtD
Raloxifene—Rash—Hydroxyurea—brain cancer	0.000256	0.00357	CcSEcCtD
Raloxifene—Dermatitis—Hydroxyurea—brain cancer	0.000256	0.00357	CcSEcCtD
Raloxifene—Headache—Hydroxyurea—brain cancer	0.000254	0.00355	CcSEcCtD
Raloxifene—Infection—Etoposide—brain cancer	0.000252	0.00352	CcSEcCtD
Raloxifene—Body temperature increased—Temozolomide—brain cancer	0.000251	0.0035	CcSEcCtD
Raloxifene—Abdominal pain—Temozolomide—brain cancer	0.000251	0.0035	CcSEcCtD
Raloxifene—Thrombocytopenia—Etoposide—brain cancer	0.000249	0.00347	CcSEcCtD
Raloxifene—Skin disorder—Etoposide—brain cancer	0.000247	0.00344	CcSEcCtD
Raloxifene—Hyperhidrosis—Etoposide—brain cancer	0.000245	0.00342	CcSEcCtD
Raloxifene—Nausea—Hydroxyurea—brain cancer	0.000241	0.00336	CcSEcCtD
Raloxifene—CYP2C8—brain—brain cancer	0.000241	0.0064	CbGeAlD
Raloxifene—CYP3A4—endocrine gland—brain cancer	0.000228	0.00606	CbGeAlD
Raloxifene—Diarrhoea—Carmustine—brain cancer	0.000225	0.00313	CcSEcCtD
Raloxifene—Gastrointestinal disorder—Etoposide—brain cancer	0.000219	0.00306	CcSEcCtD
Raloxifene—Dizziness—Carmustine—brain cancer	0.000217	0.00303	CcSEcCtD
Raloxifene—Pain—Etoposide—brain cancer	0.000217	0.00303	CcSEcCtD
Raloxifene—Diarrhoea—Temozolomide—brain cancer	0.000217	0.00303	CcSEcCtD
Raloxifene—CYP2B6—brain—brain cancer	0.000216	0.00574	CbGeAlD
Raloxifene—Dizziness—Temozolomide—brain cancer	0.00021	0.00293	CcSEcCtD
Raloxifene—Vomiting—Carmustine—brain cancer	0.000209	0.00291	CcSEcCtD
Raloxifene—Gastrointestinal pain—Etoposide—brain cancer	0.000208	0.0029	CcSEcCtD
Raloxifene—Rash—Carmustine—brain cancer	0.000207	0.00289	CcSEcCtD
Raloxifene—Dermatitis—Carmustine—brain cancer	0.000207	0.00288	CcSEcCtD
Raloxifene—CYP3A4—central nervous system—brain cancer	0.000206	0.00546	CbGeAlD
Raloxifene—Headache—Carmustine—brain cancer	0.000206	0.00287	CcSEcCtD
Raloxifene—Vomiting—Temozolomide—brain cancer	0.000202	0.00281	CcSEcCtD
Raloxifene—Abdominal pain—Etoposide—brain cancer	0.000201	0.0028	CcSEcCtD
Raloxifene—Body temperature increased—Etoposide—brain cancer	0.000201	0.0028	CcSEcCtD
Raloxifene—Rash—Temozolomide—brain cancer	0.0002	0.00279	CcSEcCtD
Raloxifene—Dermatitis—Temozolomide—brain cancer	0.0002	0.00279	CcSEcCtD
Raloxifene—Headache—Temozolomide—brain cancer	0.000199	0.00277	CcSEcCtD
Raloxifene—Nausea—Carmustine—brain cancer	0.000195	0.00272	CcSEcCtD
Raloxifene—Nausea—Temozolomide—brain cancer	0.000188	0.00263	CcSEcCtD
Raloxifene—Diarrhoea—Etoposide—brain cancer	0.000174	0.00242	CcSEcCtD
Raloxifene—Dizziness—Etoposide—brain cancer	0.000168	0.00234	CcSEcCtD
Raloxifene—Vomiting—Etoposide—brain cancer	0.000161	0.00225	CcSEcCtD
Raloxifene—Rash—Etoposide—brain cancer	0.00016	0.00223	CcSEcCtD
Raloxifene—Dermatitis—Etoposide—brain cancer	0.00016	0.00223	CcSEcCtD
Raloxifene—Headache—Etoposide—brain cancer	0.000159	0.00222	CcSEcCtD
Raloxifene—Nausea—Etoposide—brain cancer	0.000151	0.0021	CcSEcCtD
Raloxifene—AOX1—Metabolism—CYP2C9—brain cancer	0.000106	0.00154	CbGpPWpGaD
Raloxifene—ESR1—LKB1 signaling events—TP53—brain cancer	0.000104	0.00152	CbGpPWpGaD
Raloxifene—HTR6—GPCR ligand binding—SHH—brain cancer	0.000103	0.0015	CbGpPWpGaD
Raloxifene—HTR6—Signaling by GPCR—PTCH2—brain cancer	0.000102	0.00149	CbGpPWpGaD
Raloxifene—ESR1—Leptin signaling pathway—CCND1—brain cancer	0.000101	0.00148	CbGpPWpGaD
Raloxifene—ESR1—Integrated Pancreatic Cancer Pathway—BRCA2—brain cancer	0.0001	0.00146	CbGpPWpGaD
Raloxifene—CYP19A1—Integrated Breast Cancer Pathway—CDK4—brain cancer	0.0001	0.00146	CbGpPWpGaD
Raloxifene—ESR1—Integrated Pancreatic Cancer Pathway—SIRT1—brain cancer	9.81e-05	0.00143	CbGpPWpGaD
Raloxifene—ESR2—SIDS Susceptibility Pathways—VEGFA—brain cancer	9.74e-05	0.00142	CbGpPWpGaD
Raloxifene—HTR6—GPCR ligand binding—PTCH1—brain cancer	9.73e-05	0.00142	CbGpPWpGaD
Raloxifene—HTR6—GPCR ligand binding—SMO—brain cancer	9.73e-05	0.00142	CbGpPWpGaD
Raloxifene—ESR1—Integrated Pancreatic Cancer Pathway—CCNE1—brain cancer	9.69e-05	0.00141	CbGpPWpGaD
Raloxifene—ESR2—Integrated Pancreatic Cancer Pathway—CCND1—brain cancer	9.5e-05	0.00139	CbGpPWpGaD
Raloxifene—ESR1—Signaling by ERBB4—IRS2—brain cancer	9.49e-05	0.00139	CbGpPWpGaD
Raloxifene—ESR2—Integrated Pancreatic Cancer Pathway—CTNNB1—brain cancer	9.41e-05	0.00137	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—OR14C36—brain cancer	9.38e-05	0.00137	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—OR4C12—brain cancer	9.38e-05	0.00137	CbGpPWpGaD
Raloxifene—HTR2B—GPCR ligand binding—SHH—brain cancer	9.37e-05	0.00137	CbGpPWpGaD
Raloxifene—HTR2B—Signaling by GPCR—PTCH2—brain cancer	9.34e-05	0.00136	CbGpPWpGaD
Raloxifene—CYP3A4—Biological oxidations—CYP2C9—brain cancer	9.34e-05	0.00136	CbGpPWpGaD
Raloxifene—AOX1—Disease—IDH1—brain cancer	9.24e-05	0.00135	CbGpPWpGaD
Raloxifene—ESR1—Validated nuclear estrogen receptor alpha network—MYC—brain cancer	9.21e-05	0.00135	CbGpPWpGaD
Raloxifene—CYP3A4—Metapathway biotransformation—CYP2C9—brain cancer	9.21e-05	0.00134	CbGpPWpGaD
Raloxifene—ESR1—Integrated Pancreatic Cancer Pathway—PDGFRA—brain cancer	9.01e-05	0.00131	CbGpPWpGaD
Raloxifene—AOX1—Metabolism—BSG—brain cancer	9e-05	0.00131	CbGpPWpGaD
Raloxifene—CYP19A1—Metabolism of lipids and lipoproteins—IDH1—brain cancer	8.98e-05	0.00131	CbGpPWpGaD
Raloxifene—ESR1—Integrated Breast Cancer Pathway—CDK4—brain cancer	8.95e-05	0.00131	CbGpPWpGaD
Raloxifene—HTR2B—GPCR ligand binding—PTCH1—brain cancer	8.89e-05	0.0013	CbGpPWpGaD
Raloxifene—HTR2B—GPCR ligand binding—SMO—brain cancer	8.89e-05	0.0013	CbGpPWpGaD
Raloxifene—HTR6—GPCR downstream signaling—ABR—brain cancer	8.84e-05	0.00129	CbGpPWpGaD
Raloxifene—ESR1—Regulation of Telomerase—MYC—brain cancer	8.78e-05	0.00128	CbGpPWpGaD
Raloxifene—AOX1—Disease—HEY1—brain cancer	8.76e-05	0.00128	CbGpPWpGaD
Raloxifene—ESR1—Leptin signaling pathway—STAT3—brain cancer	8.73e-05	0.00128	CbGpPWpGaD
Raloxifene—AOX1—Disease—DLL1—brain cancer	8.59e-05	0.00125	CbGpPWpGaD
Raloxifene—ESR1—Regulation of Telomerase—EGFR—brain cancer	8.59e-05	0.00125	CbGpPWpGaD
Raloxifene—ESR1—Integrated Pancreatic Cancer Pathway—PCNA—brain cancer	8.58e-05	0.00125	CbGpPWpGaD
Raloxifene—ESR1—AP-1 transcription factor network—MYC—brain cancer	8.58e-05	0.00125	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—OR4C12—brain cancer	8.56e-05	0.00125	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—OR14C36—brain cancer	8.56e-05	0.00125	CbGpPWpGaD
Raloxifene—ESR2—Integrated Pancreatic Cancer Pathway—VEGFA—brain cancer	8.28e-05	0.00121	CbGpPWpGaD
Raloxifene—HTR2B—GPCR downstream signaling—ABR—brain cancer	8.07e-05	0.00118	CbGpPWpGaD
Raloxifene—HTR6—Signaling by GPCR—ABR—brain cancer	8.03e-05	0.00117	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—DTX2—brain cancer	7.97e-05	0.00116	CbGpPWpGaD
Raloxifene—AOX1—Metabolism—IDH1—brain cancer	7.73e-05	0.00113	CbGpPWpGaD
Raloxifene—ESR1—Regulation of nuclear SMAD2/3 signaling—MYC—brain cancer	7.63e-05	0.00111	CbGpPWpGaD
Raloxifene—ESR2—Integrated Pancreatic Cancer Pathway—MYC—brain cancer	7.62e-05	0.00111	CbGpPWpGaD
Raloxifene—ESR2—Integrated Pancreatic Cancer Pathway—EGFR—brain cancer	7.45e-05	0.00109	CbGpPWpGaD
Raloxifene—ESR1—Integrated Pancreatic Cancer Pathway—CDK4—brain cancer	7.42e-05	0.00108	CbGpPWpGaD
Raloxifene—HTR2B—Signaling by GPCR—ABR—brain cancer	7.33e-05	0.00107	CbGpPWpGaD
Raloxifene—AOX1—Disease—SHH—brain cancer	7.3e-05	0.00107	CbGpPWpGaD
Raloxifene—AOX1—Disease—ENO2—brain cancer	7.3e-05	0.00107	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—DTX2—brain cancer	7.28e-05	0.00106	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—OR4C12—brain cancer	7.13e-05	0.00104	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—OR14C36—brain cancer	7.13e-05	0.00104	CbGpPWpGaD
Raloxifene—ESR1—AP-1 transcription factor network—TP53—brain cancer	7.04e-05	0.00103	CbGpPWpGaD
Raloxifene—ESR1—Integrated Pancreatic Cancer Pathway—APC—brain cancer	6.98e-05	0.00102	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	6.68e-05	0.000975	CbGpPWpGaD
Raloxifene—ESR1—Signaling by ERBB4—ERBB2—brain cancer	6.51e-05	0.00095	CbGpPWpGaD
Raloxifene—CYP19A1—Integrated Breast Cancer Pathway—CCND1—brain cancer	6.46e-05	0.000943	CbGpPWpGaD
Raloxifene—ESR2—Gene Expression—DNMT1—brain cancer	6.43e-05	0.000939	CbGpPWpGaD
Raloxifene—CYP19A1—Integrated Breast Cancer Pathway—CTNNB1—brain cancer	6.39e-05	0.000934	CbGpPWpGaD
Raloxifene—ESR2—Integrated Pancreatic Cancer Pathway—TP53—brain cancer	6.26e-05	0.000914	CbGpPWpGaD
Raloxifene—AOX1—Metabolism—ENO2—brain cancer	6.11e-05	0.000893	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—DTX2—brain cancer	6.06e-05	0.000885	CbGpPWpGaD
Raloxifene—ESR1—Generic Transcription Pathway—ESR2—brain cancer	6.05e-05	0.000883	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—PTCH2—brain cancer	6.04e-05	0.000882	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—HES5—brain cancer	5.85e-05	0.000854	CbGpPWpGaD
Raloxifene—ESR1—Integrated Breast Cancer Pathway—CCND1—brain cancer	5.78e-05	0.000844	CbGpPWpGaD
Raloxifene—ESR1—Generic Transcription Pathway—NOTCH2—brain cancer	5.73e-05	0.000837	CbGpPWpGaD
Raloxifene—ESR1—Integrated Breast Cancer Pathway—CTNNB1—brain cancer	5.72e-05	0.000836	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—STRADA—brain cancer	5.68e-05	0.000829	CbGpPWpGaD
Raloxifene—CYP19A1—Integrated Breast Cancer Pathway—VEGFA—brain cancer	5.63e-05	0.000822	CbGpPWpGaD
Raloxifene—HTR6—GPCR downstream signaling—TRPC6—brain cancer	5.6e-05	0.000817	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—PTCH2—brain cancer	5.52e-05	0.000805	CbGpPWpGaD
Raloxifene—ESR2—Gene Expression—NOTCH2—brain cancer	5.47e-05	0.000799	CbGpPWpGaD
Raloxifene—CYP19A1—Metabolism—CYP2C9—brain cancer	5.47e-05	0.000799	CbGpPWpGaD
Raloxifene—ESR1—Integrated Pancreatic Cancer Pathway—ERBB2—brain cancer	5.42e-05	0.000792	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—HES5—brain cancer	5.34e-05	0.00078	CbGpPWpGaD
Raloxifene—AOX1—Disease—VAV1—brain cancer	5.27e-05	0.00077	CbGpPWpGaD
Raloxifene—HTR6—Signaling by GPCR—SHH—brain cancer	5.27e-05	0.000769	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—STRADA—brain cancer	5.19e-05	0.000757	CbGpPWpGaD
Raloxifene—CYP19A1—Integrated Breast Cancer Pathway—MYC—brain cancer	5.18e-05	0.000756	CbGpPWpGaD
Raloxifene—HTR2B—GPCR downstream signaling—TRPC6—brain cancer	5.11e-05	0.000746	CbGpPWpGaD
Raloxifene—HTR6—Signaling by GPCR—TRPC6—brain cancer	5.08e-05	0.000742	CbGpPWpGaD
Raloxifene—CYP19A1—Integrated Breast Cancer Pathway—EGFR—brain cancer	5.07e-05	0.00074	CbGpPWpGaD
Raloxifene—EBP—Metabolism—PIK3CG—brain cancer	5.06e-05	0.000739	CbGpPWpGaD
Raloxifene—ESR1—Integrated Breast Cancer Pathway—VEGFA—brain cancer	5.04e-05	0.000736	CbGpPWpGaD
Raloxifene—HTR6—Signaling by GPCR—SMO—brain cancer	5e-05	0.000729	CbGpPWpGaD
Raloxifene—HTR6—Signaling by GPCR—PTCH1—brain cancer	5e-05	0.000729	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism of lipids and lipoproteins—IDH1—brain cancer	4.88e-05	0.000713	CbGpPWpGaD
Raloxifene—HTR2B—Signaling by GPCR—SHH—brain cancer	4.81e-05	0.000702	CbGpPWpGaD
Raloxifene—ESR1—Integrated Pancreatic Cancer Pathway—CCND1—brain cancer	4.79e-05	0.000699	CbGpPWpGaD
Raloxifene—ESR1—Integrated Pancreatic Cancer Pathway—CTNNB1—brain cancer	4.74e-05	0.000693	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—ABR—brain cancer	4.74e-05	0.000692	CbGpPWpGaD
Raloxifene—ESR2—Gene Expression—SIRT1—brain cancer	4.65e-05	0.000679	CbGpPWpGaD
Raloxifene—CYP19A1—Metabolism—BSG—brain cancer	4.65e-05	0.000679	CbGpPWpGaD
Raloxifene—HTR2B—Signaling by GPCR—TRPC6—brain cancer	4.64e-05	0.000677	CbGpPWpGaD
Raloxifene—ESR1—Integrated Breast Cancer Pathway—MYC—brain cancer	4.64e-05	0.000677	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—PTCH2—brain cancer	4.59e-05	0.000671	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—GLI2—brain cancer	4.58e-05	0.000669	CbGpPWpGaD
Raloxifene—HTR2B—Signaling by GPCR—SMO—brain cancer	4.56e-05	0.000666	CbGpPWpGaD
Raloxifene—HTR2B—Signaling by GPCR—PTCH1—brain cancer	4.56e-05	0.000666	CbGpPWpGaD
Raloxifene—AOX1—Disease—HES1—brain cancer	4.54e-05	0.000662	CbGpPWpGaD
Raloxifene—ESR1—Integrated Breast Cancer Pathway—EGFR—brain cancer	4.54e-05	0.000662	CbGpPWpGaD
Raloxifene—ESR1—Signaling by ERBB4—EGFR—brain cancer	4.51e-05	0.000659	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—HES5—brain cancer	4.45e-05	0.00065	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—ABR—brain cancer	4.33e-05	0.000632	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—STRADA—brain cancer	4.32e-05	0.000631	CbGpPWpGaD
Raloxifene—AOX1—Disease—PDGFRA—brain cancer	4.32e-05	0.000631	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—GLI1—brain cancer	4.31e-05	0.000629	CbGpPWpGaD
Raloxifene—CYP19A1—Integrated Breast Cancer Pathway—TP53—brain cancer	4.25e-05	0.000621	CbGpPWpGaD
Raloxifene—HTR6—GPCR downstream signaling—VAV1—brain cancer	4.19e-05	0.000612	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—GLI2—brain cancer	4.18e-05	0.00061	CbGpPWpGaD
Raloxifene—ESR1—Integrated Pancreatic Cancer Pathway—VEGFA—brain cancer	4.18e-05	0.00061	CbGpPWpGaD
Raloxifene—HTR2B—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—brain cancer	4.1e-05	0.000599	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—SUFU—brain cancer	4.08e-05	0.000596	CbGpPWpGaD
Raloxifene—CYP19A1—Metabolism—IDH1—brain cancer	4e-05	0.000584	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—GFAP—brain cancer	3.94e-05	0.000575	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—GLI1—brain cancer	3.93e-05	0.000574	CbGpPWpGaD
Raloxifene—ESR1—Integrated Pancreatic Cancer Pathway—MYC—brain cancer	3.84e-05	0.000561	CbGpPWpGaD
Raloxifene—HTR2B—GPCR downstream signaling—VAV1—brain cancer	3.83e-05	0.000559	CbGpPWpGaD
Raloxifene—ESR1—Integrated Breast Cancer Pathway—TP53—brain cancer	3.81e-05	0.000556	CbGpPWpGaD
Raloxifene—HTR6—Signaling by GPCR—VAV1—brain cancer	3.81e-05	0.000556	CbGpPWpGaD
Raloxifene—AOX1—Disease—IRS2—brain cancer	3.79e-05	0.000554	CbGpPWpGaD
Raloxifene—ESR2—Generic Transcription Pathway—MYC—brain cancer	3.79e-05	0.000553	CbGpPWpGaD
Raloxifene—ESR1—Integrated Pancreatic Cancer Pathway—EGFR—brain cancer	3.76e-05	0.000549	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—HEY1—brain cancer	3.73e-05	0.000545	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—SUFU—brain cancer	3.73e-05	0.000544	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—DLL1—brain cancer	3.66e-05	0.000534	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—ABR—brain cancer	3.61e-05	0.000526	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—GFAP—brain cancer	3.59e-05	0.000525	CbGpPWpGaD
Raloxifene—CYP2B6—Metabolism—CYP2C9—brain cancer	3.51e-05	0.000513	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—GLI2—brain cancer	3.48e-05	0.000508	CbGpPWpGaD
Raloxifene—HTR2B—Signaling by GPCR—VAV1—brain cancer	3.48e-05	0.000507	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—HEY1—brain cancer	3.41e-05	0.000497	CbGpPWpGaD
Raloxifene—AOX1—Disease—APC—brain cancer	3.35e-05	0.000489	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—DLL1—brain cancer	3.34e-05	0.000488	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—GLI1—brain cancer	3.27e-05	0.000478	CbGpPWpGaD
Raloxifene—CYP19A1—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	3.26e-05	0.000476	CbGpPWpGaD
Raloxifene—ESR1—Gene Expression—DNMT1—brain cancer	3.24e-05	0.000474	CbGpPWpGaD
Raloxifene—CYP19A1—Metabolism—ENO2—brain cancer	3.16e-05	0.000462	CbGpPWpGaD
Raloxifene—ESR1—Integrated Pancreatic Cancer Pathway—TP53—brain cancer	3.16e-05	0.000461	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—SHH—brain cancer	3.11e-05	0.000454	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—SUFU—brain cancer	3.1e-05	0.000453	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—TRPC6—brain cancer	3e-05	0.000438	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—GFAP—brain cancer	2.99e-05	0.000437	CbGpPWpGaD
Raloxifene—CYP2B6—Metabolism—BSG—brain cancer	2.99e-05	0.000436	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism—CYP2C9—brain cancer	2.97e-05	0.000434	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—SMO—brain cancer	2.95e-05	0.000431	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—PTCH1—brain cancer	2.95e-05	0.000431	CbGpPWpGaD
Raloxifene—ESR1—Gene Expression—ESR2—brain cancer	2.91e-05	0.000425	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—SHH—brain cancer	2.84e-05	0.000415	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—HEY1—brain cancer	2.84e-05	0.000414	CbGpPWpGaD
Raloxifene—AOX1—Metabolism—PIK3CG—brain cancer	2.8e-05	0.00041	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—DLL1—brain cancer	2.78e-05	0.000406	CbGpPWpGaD
Raloxifene—ESR1—Gene Expression—NOTCH2—brain cancer	2.76e-05	0.000403	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—TRPC6—brain cancer	2.74e-05	0.0004	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—PTCH1—brain cancer	2.69e-05	0.000393	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—SMO—brain cancer	2.69e-05	0.000393	CbGpPWpGaD
Raloxifene—HTR6—GPCR downstream signaling—PIK3CG—brain cancer	2.66e-05	0.000389	CbGpPWpGaD
Raloxifene—AOX1—Disease—ERBB2—brain cancer	2.6e-05	0.00038	CbGpPWpGaD
Raloxifene—CYP2B6—Metabolism—IDH1—brain cancer	2.57e-05	0.000375	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism—BSG—brain cancer	2.53e-05	0.000369	CbGpPWpGaD
Raloxifene—HTR2B—GPCR downstream signaling—PIK3CG—brain cancer	2.43e-05	0.000355	CbGpPWpGaD
Raloxifene—HTR6—Signaling by GPCR—PIK3CG—brain cancer	2.42e-05	0.000353	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—SHH—brain cancer	2.37e-05	0.000346	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—NOTCH2—brain cancer	2.36e-05	0.000344	CbGpPWpGaD
Raloxifene—ESR1—Gene Expression—SIRT1—brain cancer	2.35e-05	0.000342	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—TRPC6—brain cancer	2.28e-05	0.000333	CbGpPWpGaD
Raloxifene—AOX1—Disease—CTNNB1—brain cancer	2.28e-05	0.000332	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—VAV1—brain cancer	2.25e-05	0.000328	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—PTCH1—brain cancer	2.24e-05	0.000328	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—SMO—brain cancer	2.24e-05	0.000328	CbGpPWpGaD
Raloxifene—HTR2B—Signaling by GPCR—PIK3CG—brain cancer	2.21e-05	0.000322	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism—IDH1—brain cancer	2.17e-05	0.000318	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—NOTCH2—brain cancer	2.15e-05	0.000314	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—VAV1—brain cancer	2.05e-05	0.0003	CbGpPWpGaD
Raloxifene—CYP2B6—Metabolism—ENO2—brain cancer	2.03e-05	0.000296	CbGpPWpGaD
Raloxifene—AOX1—Disease—STAT3—brain cancer	1.98e-05	0.00029	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—HES1—brain cancer	1.93e-05	0.000282	CbGpPWpGaD
Raloxifene—ESR1—Generic Transcription Pathway—MYC—brain cancer	1.91e-05	0.000279	CbGpPWpGaD
Raloxifene—HTR6—GPCR downstream signaling—IL2—brain cancer	1.87e-05	0.000273	CbGpPWpGaD
Raloxifene—AOX1—Disease—MYC—brain cancer	1.84e-05	0.000269	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—PDGFRA—brain cancer	1.84e-05	0.000269	CbGpPWpGaD
Raloxifene—ESR2—Gene Expression—MYC—brain cancer	1.82e-05	0.000266	CbGpPWpGaD
Raloxifene—AOX1—Disease—EGFR—brain cancer	1.8e-05	0.000263	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—NOTCH2—brain cancer	1.79e-05	0.000262	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—SPP1—brain cancer	1.79e-05	0.000261	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	1.77e-05	0.000259	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—HES1—brain cancer	1.77e-05	0.000258	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism—ENO2—brain cancer	1.72e-05	0.000251	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—VAV1—brain cancer	1.71e-05	0.00025	CbGpPWpGaD
Raloxifene—HTR2B—GPCR downstream signaling—IL2—brain cancer	1.71e-05	0.00025	CbGpPWpGaD
Raloxifene—HTR6—Signaling by GPCR—IL2—brain cancer	1.7e-05	0.000248	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—PDGFRA—brain cancer	1.68e-05	0.000245	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—SPP1—brain cancer	1.63e-05	0.000238	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—IRS2—brain cancer	1.62e-05	0.000236	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—CYP2C9—brain cancer	1.6e-05	0.000233	CbGpPWpGaD
Raloxifene—HTR2B—Signaling by GPCR—IL2—brain cancer	1.55e-05	0.000227	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—IRS2—brain cancer	1.48e-05	0.000215	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—HES1—brain cancer	1.47e-05	0.000215	CbGpPWpGaD
Raloxifene—CYP19A1—Metabolism—PIK3CG—brain cancer	1.45e-05	0.000212	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—PIK3CG—brain cancer	1.43e-05	0.000208	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—APC—brain cancer	1.43e-05	0.000208	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—PDGFRA—brain cancer	1.4e-05	0.000204	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—SPP1—brain cancer	1.36e-05	0.000198	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—BSG—brain cancer	1.36e-05	0.000198	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—APC—brain cancer	1.3e-05	0.00019	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—PIK3CG—brain cancer	1.3e-05	0.00019	CbGpPWpGaD
Raloxifene—HTR6—Signaling by GPCR—EGFR—brain cancer	1.3e-05	0.00019	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—IRS2—brain cancer	1.23e-05	0.000179	CbGpPWpGaD
Raloxifene—HTR2B—Signaling by GPCR—EGFR—brain cancer	1.19e-05	0.000173	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—IDH1—brain cancer	1.17e-05	0.00017	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—RELA—brain cancer	1.12e-05	0.000163	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—ERBB2—brain cancer	1.11e-05	0.000162	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—PIK3CG—brain cancer	1.09e-05	0.000159	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—APC—brain cancer	1.09e-05	0.000159	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—RELA—brain cancer	1.02e-05	0.000149	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—ERBB2—brain cancer	1.01e-05	0.000148	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—IL2—brain cancer	1e-05	0.000147	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—CCND1—brain cancer	9.8e-06	0.000143	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—CTNNB1—brain cancer	9.7e-06	0.000142	CbGpPWpGaD
Raloxifene—CYP2B6—Metabolism—PIK3CG—brain cancer	9.32e-06	0.000136	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—ENO2—brain cancer	9.23e-06	0.000135	CbGpPWpGaD
Raloxifene—ESR1—Gene Expression—MYC—brain cancer	9.19e-06	0.000134	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—IL2—brain cancer	9.17e-06	0.000134	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—CCND1—brain cancer	8.94e-06	0.000131	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—CTNNB1—brain cancer	8.85e-06	0.000129	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—VEGFA—brain cancer	8.54e-06	0.000125	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—RELA—brain cancer	8.48e-06	0.000124	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—STAT3—brain cancer	8.46e-06	0.000123	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—ERBB2—brain cancer	8.43e-06	0.000123	CbGpPWpGaD
Raloxifene—CYP2C8—Metabolism—PIK3CG—brain cancer	7.89e-06	0.000115	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—MYC—brain cancer	7.86e-06	0.000115	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—VEGFA—brain cancer	7.8e-06	0.000114	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—STAT3—brain cancer	7.72e-06	0.000113	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—EGFR—brain cancer	7.69e-06	0.000112	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—IL2—brain cancer	7.64e-06	0.000112	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—CCND1—brain cancer	7.45e-06	0.000109	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—CTNNB1—brain cancer	7.38e-06	0.000108	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—MYC—brain cancer	7.17e-06	0.000105	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—EGFR—brain cancer	7.02e-06	0.000102	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—VEGFA—brain cancer	6.49e-06	9.48e-05	CbGpPWpGaD
Raloxifene—HTR6—Signaling Pathways—TP53—brain cancer	6.45e-06	9.42e-05	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—STAT3—brain cancer	6.43e-06	9.39e-05	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—MYC—brain cancer	5.97e-06	8.72e-05	CbGpPWpGaD
Raloxifene—HTR2B—Signaling Pathways—TP53—brain cancer	5.89e-06	8.6e-05	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—EGFR—brain cancer	5.84e-06	8.53e-05	CbGpPWpGaD
Raloxifene—ESR1—Signaling Pathways—TP53—brain cancer	4.91e-06	7.16e-05	CbGpPWpGaD
Raloxifene—CYP3A4—Metabolism—PIK3CG—brain cancer	4.23e-06	6.18e-05	CbGpPWpGaD
